DIAGNOSTIC ACCURACY OF T2 WEIGHTED IMAGING AND GADOLINIUM ENHANCED MRI IN DIAGNOSIS AND STAGING OF URINARY BLADDER CARCINOMA TAKING HISTOPATHOLOGY AS GOLD STANDARDS

S MAQSOOD; HH MUGHAL

doi:10.54112/bcsrj.v2023i1.622

Authors

S MAQSOOD Department of Radiology, Benazir Bhutto Hospital, Rawalpindi (BBH) Rawalpindi, Pakistan
HH MUGHAL Department of Radiology, Benazir Bhutto Hospital, Rawalpindi (BBH) Rawalpindi, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.622

Keywords:

Urinary Bladder Carcinoma, T2-Weighted Imaging, Gadolinium-Enhanced MRI, Transurethral Resection of Bladder Tumor (TURBT), Radical Cystectomy, Histopathology Introduction

Abstract

Urinary bladder carcinoma (UBC) diagnosis and staging are critical for treatment planning and patient prognosis. This histopathology-guided study evaluates the diagnostic accuracy of T2-weighted imaging (T2WI) and gadolinium-enhanced MRI (GE-MRI) in UBC diagnosis and staging, with histopathology as the gold standard. A total of 30 patients with suspected or confirmed UBC were included in the study. T2WI and GE-MRI were performed, and imaging findings were compared with histopathological results obtained from transurethral resection of bladder tumor (TURBT) or radical cystectomy specimens. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of T2WI and GE-MRI were calculated. The results demonstrate that T2WI had a sensitivity of 85%, specificity of 80%, PPV of 90%, NPV of 75%, and overall accuracy of 83.3% in diagnosing UBC. GE-MRI showed a sensitivity of 90%, specificity of 85%, PPV of 92%, NPV of 80%, and overall accuracy of 88.3%. Both imaging modalities exhibited high diagnostic accuracy in detecting UBC lesions and staging tumor extent. In conclusion, T2WI and GE-MRI are valuable tools for UBC diagnosis and staging, providing essential information for treatment planning and patient management.

Downloads

Download data is not yet available.

References

Belpomme, D., Irigaray, P., Sasco, A., Newby, J., Howard, V., Clapp, R., and Hardell, L. (2007). The growing incidence of cancer: role of lifestyle and screening detection. International journal of oncology 30, 1037-1049.

Crozier, J., Papa, N., Perera, M., Ngo, B., Bolton, D., Sengupta, S., and Lawrentschuk, N. (2019). Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis. World journal of urology 37, 667-690.

Diamantopoulos, L. N., Winters, B. R., Grivas, P., Ngo, S. D., Zeng, J., Hsieh, A. C., Gore, J. L., Liao, J. J., Yu, E. Y., and Schade, G. R. (2019). Bladder cancer multidisciplinary clinic (BCMC) model influences disease assessment and impacts treatment recommendations. Bladder Cancer 5, 289-298.

Goel, V., Parihar, P. S., Parihar, A., Goel, A. K., Waghwani, K., Gupta, R., and Bhutekar, U. (2016). Accuracy of MRI in prediction of tumour thickness and nodal stage in oral tongue and gingivobuccal cancer with clinical correlation and staging. Journal of clinical and diagnostic research: JCDR 10, TC01.

Hensley, P. J., Panebianco, V., Pietzak, E., Kutikov, A., Vikram, R., Galsky, M. D., Shariat, S. F., Roupret, M., and Kamat, A. M. (2022). Contemporary staging for muscle-invasive bladder Cancer: accuracy and limitations. European Urology Oncology 5, 403-411.

Irigaray, P., Newby, J., Clapp, R., Hardell, L., Howard, V., Montagnier, L., Epstein, S., and Belpomme, D. (2007). Lifestyle-related factors and environmental agents causing cancer: an overview. Biomedicine & Pharmacotherapy 61, 640-658.

Kamoun, A., de Reyniès, A., Allory, Y., Sjödahl, G., Robertson, A. G., Seiler, R., Hoadley, K. A., Groeneveld, C. S., Al-Ahmadie, H., and Choi, W. (2020). A consensus molecular classification of muscle-invasive bladder cancer. European urology 77, 420-433.

Mechtler, L. (2009). Neuroimaging in neuro-oncology. Neurologic clinics 27, 171-201.

Pandith, A. A., and Siddiqi, M. A. (2012). Burden of cancers in the valley of Kashmir: 5 year epidemiological study reveals a different scenario. Tumor Biology 33, 1629-1637.

Panebianco, V., De Berardinis, E., Barchetti, G., Simone, G., Leonardo, C., Grompone, M. D., Del Monte, M., Carano, D., Gallucci, M., and Catto, J. (2017). An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer. European radiology 27, 3759-3766.

Papakonstantinou, O., Isaac, A., Dalili, D., and Noebauer-Huhmann, I.-M. (2019). T2-weighted hypointense tumors and tumor-like lesions. In "Seminars in Musculoskeletal Radiology", Vol. 23, pp. 058-075. Thieme Medical Publishers.

Pinker, K., Bogner, W., Baltzer, P., Gruber, S., Bickel, H., Brueck, B., Trattnig, S., Weber, M., Dubsky, P., and Bago-Horvath, Z. (2014). Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging. Investigative radiology 49, 421-430.

Roy, S. M., and Riley, M. A. (2019). Evaluation of the potential of colicins to prevent extraluminal contamination of urinary catheters by Escherichia coli. International journal of antimicrobial agents 54, 619-625.

Shore, N. D., Morgans, A. K., El-Haddad, G., Srinivas, S., and Abramowitz, M. (2022). Addressing Challenges and Controversies in the Management of Prostate Cancer with Multidisciplinary Teams. Targeted oncology 17, 709-725.

Yanev, P., van Tilborg, G. A., van der Toorn, A., Kong, X., Stowe, A. M., and Dijkhuizen, R. M. (2022). Prolonged release of VEGF and Ang1 from intralesionally implanted hydrogel promotes perilesional vascularization and functional recovery after experimental ischemic stroke. Journal of Cerebral Blood Flow & Metabolism 42, 1033-1048.